Linagliptin

Drug Usage Statistics, United States, 2007 - 2017

Number of Prescriptions Over Time (2007 - 2017)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2011 778 -
2012 666  112
2013 294  372
2014 299  5
Year Rank Change
2015 219  80
2016 196  23
2017 200  4

Patient Out-Of-Pocket Cost Over Time (2007 - 2017)

"Out-of-pocket" cost refers to the payment made by the patient (either cash price or the copay amount). This value does not include reimbursement from a third party payer (eg, Medicare or private insurance) and does not represent the total drug cost.

Usage Statistics of Related Drugs

Drug Name Total Prescriptions (2017)
Sitagliptin Phosphate 8,485,404
Metformin Hydrochloride; Sitagliptin Phosphate 4,735,730
Linagliptin (this drug) 2,823,706
Saxagliptin Hydrochloride 1,054,309

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Tradjenta
Generic Drug Synonyms and Salts
  • Linagliptin

FDA Approval Information

Established Pharmacologic Class (EPC): Dipeptidyl Peptidase 4 Inhibitor
Initial FDA approval date: 5/2/2011
First FDA applicant: Rx
First dosage form: Tablet (oral)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2007-2017. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 20.1. Read more about the ClinCalc DrugStats database.

Search

Related Links

Follow Us!

New and Popular

Loading...

Open Menu

Cite This Page

Show AMA citation

RxHero - Complete quests, earn points ... Develop rock-solid drug therapy knowledge
 
©2020 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Jul 19, 2018
Back to Top
Top